BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 26809245)

  • 1. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives.
    Magro-Checa C; Zirkzee EJ; Huizinga TW; Steup-Beekman GM
    Drugs; 2016 Mar; 76(4):459-83. PubMed ID: 26809245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of neuropsychiatric manifestations in systemic lupus erythematosus.
    Fujieda Y
    Immunol Med; 2020 Dec; 43(4):135-141. PubMed ID: 32459601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of multidisciplinary reassessment in attribution of neuropsychiatric events to systemic lupus erythematosus: prospective data from the Leiden NPSLE cohort.
    Magro-Checa C; Zirkzee EJ; Beaart-van de Voorde LJJ; Middelkoop HA; van der Wee NJ; Huisman MV; Eikenboom J; Kruyt ND; van Buchem MA; Huizinga TWJ; Steup-Beekman GM
    Rheumatology (Oxford); 2017 Oct; 56(10):1676-1683. PubMed ID: 28339952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach.
    Sanna G; Bertolaccini ML; Khamashta MA
    Curr Pharm Des; 2008; 14(13):1261-9. PubMed ID: 18537650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review.
    Constantin A; Năstase D; Tulbă D; Bălănescu P; Băicuș C
    Lupus; 2020 Oct; 29(12):1509-1519. PubMed ID: 32757735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review.
    Papachristos DA; Oon S; Hanly JG; Nikpour M
    Semin Arthritis Rheum; 2021 Feb; 51(1):49-71. PubMed ID: 33360230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management.
    Tayer-Shifman OE; Bingham KS; Touma Z
    Drugs Aging; 2022 Feb; 39(2):129-142. PubMed ID: 34913146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropsychiatric Systemic Lupus Erythematosus].
    Tanaka Y
    Brain Nerve; 2016 Sep; 68(9):1035-1048. PubMed ID: 27667489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE.
    Shimizu Y; Yasuda S; Kako Y; Nakagawa S; Kanda M; Hisada R; Ohmura K; Shimamura S; Shida H; Fujieda Y; Kato M; Oku K; Bohgaki T; Horita T; Kusumi I; Atsumi T
    Autoimmun Rev; 2016 Aug; 15(8):786-94. PubMed ID: 27016478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of neuropsychiatric lupus.
    Kivity S; Baker B; Arango MT; Chapman J; Shoenfeld Y
    Expert Rev Clin Pharmacol; 2016; 9(1):103-8. PubMed ID: 26559084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges.
    Sarwar S; Mohamed AS; Rogers S; Sarmast ST; Kataria S; Mohamed KH; Khalid MZ; Saeeduddin MO; Shiza ST; Ahmad S; Awais A; Singh R
    Cureus; 2021 Sep; 13(9):e17969. PubMed ID: 34667659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus.
    Neuwelt CM; Lacks S; Kaye BR; Ellman JB; Borenstein DG
    Am J Med; 1995 Jan; 98(1):32-41. PubMed ID: 7825616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.
    Ercan E; Ingo C; Tritanon O; Magro-Checa C; Smith A; Smith S; Huizinga T; van Buchem MA; Ronen I
    Neuroimage Clin; 2015; 8():337-44. PubMed ID: 26106559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric systemic lupus erythematosus.
    Popescu A; Kao AH
    Curr Neuropharmacol; 2011 Sep; 9(3):449-57. PubMed ID: 22379459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
    Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric Systemic Lupus Erythematosus: A Remaining Challenge.
    Mrak D; Bonelli M; Radner H
    Curr Pharm Des; 2022; 28(11):881-891. PubMed ID: 35549864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause.
    Steup-Beekman GM; Zirkzee EJ; Cohen D; Gahrmann BM; Emmer BJ; Steens SC; Bollen EL; van Buchem MA; Huizinga TW
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii76-9. PubMed ID: 23253914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, characterization, and diagnosis of neuropsychiatric events in systemic lupus erythematosus.
    de Amorim JC; Frittoli RB; Pereira D; Postal M; Dertkigil SSJ; Reis F; Costallat LT; Appenzeller S
    Expert Rev Clin Immunol; 2019 Apr; 15(4):407-416. PubMed ID: 30632405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.